Zevra Therapeutics ZVRA
NASDAQ ZVRA
$10.54 -0.43 (-3.92%)
As of: Oct 1, 2026 · 1:00 PM EDT

Zevra Therapeutics (ZVRA) Short term Debt (2014 - 2023)

Updated

Zevra Therapeutics' Short term Debt was $37.7 million in Q4 2023.

Analysis

Zevra Therapeutics (ZVRA) Short term Debt (2014 - 2023) Analysis & Trends

From Q4 2014 onward, Zevra Therapeutics has reported Short term Debt for 6 quarters.

  • Short term Debt shows a three-year compound annual growth rate of 358.9% (FY2020 to FY2023).
  • In earlier years, Short term Debt was $390,000 in FY2020.
  • The Q4 2023 figure marks the lowest quarterly Short term Debt since Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Zevra Therapeutics 650.98 Mn -161.73 Mn 38.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 37.70 Mn
Mar 31, 2021 683,000.00
Dec 31, 2020 390,000.00
Dec 31, 2015 2.04 Mn
Sep 30, 2015 1.63 Mn
Dec 31, 2014 482,000.00
API Access

Zevra Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=ZVRA&period=max&api_key=YOUR_API_KEY